{"id":"NCT00732381","sponsor":"Organon and Co","briefTitle":"Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05529)","officialTitle":"Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Relief of Nasal Congestion Associated With Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-08","primaryCompletion":"2008-11","completion":"2008-11","firstPosted":"2008-08-12","resultsPosted":"2009-11-13","lastUpdate":"2024-05-21"},"enrollment":351,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Allergic Rhinitis"],"interventions":[{"type":"DRUG","name":"Mometasone furoate nasal spray (MFNS)","otherNames":["Nasonex Nasal Spray"]},{"type":"DRUG","name":"Matching placebo nasal spray","otherNames":["Placebo"]}],"arms":[{"label":"Arm 1","type":"EXPERIMENTAL"},{"label":"Arm 2","type":"PLACEBO_COMPARATOR"}],"summary":"This study seeks to prospectively demonstrate that Nasonex is better than placebo in relieving nasal congestion in patients with seasonal allergic rhinitis.","primaryOutcome":{"measure":"The Change From Baseline in Average AM/PM PRIOR Nasal Congestion Score Over 15 Days","timeFrame":"15 days of treatment","effectByArm":[{"arm":"Mometasone Furoate Nasal Spray","deltaMin":-0.64,"sd":0.52},{"arm":"Placebo Nasal Spray","deltaMin":-0.49,"sd":0.52}],"pValues":[{"comp":"OG000 vs OG001","p":"0.006"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":9},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["21439168"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":176},"commonTop":[]}}